APR 03, 2020 6:09 PM PDT

Drug Eradicates SARS-Cov-2 in Mice

WRITTEN BY: Nouran Amin

A collaborative team of researchers joined forces to study the anti-parasitic drug, Ivermectin, and it’s role in stopping the SARS-CoV-2 virus. The studies lead to a finding that it can kill the virus in vitro within 48 hours when grown in cell culture.

"We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," says Dr. Kylie Dr Wagstaff from the Monash Biomedicine Discovery Institute.

Ivermectin is a widely available FDA-approved anti-parasitic therapeutic that has shown promise against a wide range of viruses including HIV, Dengue, Influenza and Zika virus.

Learn more about SARS-CoV-2:

"Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective -- that's the next step," Dr. Wagstaff said. "In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it's going to be a while before a vaccine is broadly available.”

How exactly does Ivermectin work on the virus? The answer to that remains unknown—however, it is believed that it may inhibit the virus actions on dampening down the host cells ability in clearing it.

"As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19," adds Dr. Leon Caly, a Senior Medical Scientist who conducts live coronavirus experiments at the Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty Institute.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 13, 2022
Microbiology
Creating a foundation for change: A tangible strategy to fight AMR
APR 13, 2022
Creating a foundation for change: A tangible strategy to fight AMR
Apply the learnings of COVID to AMR, says coalition Tackling the deadly spectre of antimicrobial resistance (AMR) requir ...
MAY 11, 2022
Cannabis Sciences
Legal Recreational Cannabis Reduces Prescription Drug Demand
MAY 11, 2022
Legal Recreational Cannabis Reduces Prescription Drug Demand
A research study published in Health Economics found a link between the availability of legal recreational cannabis, and ...
JUN 06, 2022
Drug Discovery & Development
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
JUN 06, 2022
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific sat down with Sheng Li, PhD, Program Manager, to speak about our rapid service for small-scal ...
MAY 19, 2022
Drug Discovery & Development
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
MAY 19, 2022
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published ...
JUN 11, 2022
Drug Discovery & Development
Inhaled Aerosol Vaccines More Effective than Nasal Sprays
JUN 11, 2022
Inhaled Aerosol Vaccines More Effective than Nasal Sprays
Inhaled aerosol vaccines provide more protection than nasal sprays and evoke a stronger immune response. The correspondi ...
JUN 23, 2022
Cannabis Sciences
The Latest Research on Cannabis Social Equity Programs
JUN 23, 2022
The Latest Research on Cannabis Social Equity Programs
Cannabis social equity programs are designed to increase licensure and employment opportunities for lower income and BIP ...
Loading Comments...